| Stereochemistry | ABSOLUTE |
| Molecular Formula | C15H21N5O4 |
| Molecular Weight | 335.3583 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C2N=CN=C3NC4CCCC4
InChI
InChIKey=SQMWSBKSHWARHU-SDBHATRESA-N
InChI=1S/C15H21N5O4/c21-5-9-11(22)12(23)15(24-9)20-7-18-10-13(16-6-17-14(10)20)19-8-3-1-2-4-8/h6-9,11-12,15,21-23H,1-5H2,(H,16,17,19)/t9-,11-,12-,15-/m1/s1
| Molecular Formula | C15H21N5O4 |
| Molecular Weight | 335.3583 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 6.3 nM [EC50] |
|
|
TARGET -> AGONIST |
Binding assay
IC50
52 NANOMOLAR (average) |
Showing 1 to 1 of 1 entries
